FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121675132> ?p ?o ?g. }

• W2121675132 abstract "Purpose: Tobacco use is associated with poor therapeutic outcome because it in part decreases the efficacy of conventional cancer treatments including chemotherapy and/or radiotherapy (RT). However, preclinical data suggests that nicotine replacement decreases effectiveness of cancer treatment potentially through action of the α7-nicotinic acetylcholine receptor(nAChR). The purpose of this study is to examine the role of the α7-nAChR in mediating response to RT, evaluate the effect of nAChR and non-nAChR based pharmacologic tobacco cessation agents on response to RT, and identify critical downstream signal transduction pathways associated with changes in response. Methods: α4, α7 and β2-nAChR subunit expression was verified in H460, A549 (lung cancer) and FaDu (oropharyngeal cancer) using western blot. All three cell lines were dose-escalated with nicotine, α7-nAChR selective agonists (TC 1698, PNU 282987, PHA 543613, LY 2087101), or pharmacologic tobacco cessation agents (varenicline, bupropion, hydroxybupropion, cytisine) alone or in combination with single fraction 2Gy X-ray radiation treatment. Clonogenic survival assays were used to assess cell survival and downstream activation of radioprotective pathways (Akt, ERK, mTOR, MMP2, and hypoxia inducible factor 1-alpha [HIF-1α]) were analyzed by western blot. Results: Nicotine administration and activation of the α7- nAChR by PHA 543613 or LY 2087101 were found to have a radioprotective effect in the three tested cancer cell lines as indicated by increased cell survival. Conversely, TC 1698 and PNU 282987 treatment did not modulate cell survival when in combination with radiation. Nicotine, PHA 543613, LY 2087101, TC 1698 and PNU 282987 were all shown to induce a time and dose dependent increase in p-AKT, p-ERK, and HIF-1α. However, treatment with PHA 543613 or LY 2087101 induced an increase in mTOR phosphorylation at S2448 with no change in phosphorylation with TC 1698 or PNU282987. Furthermore, other nAChR-involved agents, cytisine and varenicline, showed mixed results with varenicline inducing radioprotection while cytisine did not alter response to RT. The non-nAChR involved agents, bupropion and hydroxybupropion, did not modulate response to radiotherapy and dose escalated bupropion did not change activation of p-Akt, p-ERK, or HIF-1α. Conclusions: Collectively, these data suggests that the non-nAChR based agent bupropion and its metabolite hydroxybupropion may be the ideal tobacco cessation strategy for cancer patients in order to maintain the biologic effectiveness of radiation treatment. Data further suggests that downstream activation of mTOR may be critical to modulating α7- nAChR based changes in response to RT. Citation Format: Samantha L. Sobus, Michelle A. Romano, Graham W. Warren. The role of α7 nicotinic acetylcholine receptor activation and pharmacologic tobacco cessation agents on response to radiotherapy. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3948. doi:10.1158/1538-7445.AM2014-3948" @default.
• W2121675132 created "2016-06-24" @default.
• W2121675132 creator A5000895422 @default.
• W2121675132 creator A5073719453 @default.
• W2121675132 creator A5085219899 @default.
• W2121675132 date "2014-09-30" @default.
• W2121675132 modified "2023-09-27" @default.
• W2121675132 title "Abstract 3948: The role of α7 nicotinic acetylcholine receptor activation and pharmacologic tobacco cessation agents on response to radiotherapy" @default.
• W2121675132 doi "https://doi.org/10.1158/1538-7445.am2014-3948" @default.
• W2121675132 hasPublicationYear "2014" @default.
• W2121675132 type Work @default.
• W2121675132 sameAs 2121675132 @default.
• W2121675132 citedByCount "0" @default.
• W2121675132 crossrefType "proceedings-article" @default.
• W2121675132 hasAuthorship W2121675132A5000895422 @default.
• W2121675132 hasAuthorship W2121675132A5073719453 @default.
• W2121675132 hasAuthorship W2121675132A5085219899 @default.
• W2121675132 hasConcept C121608353 @default.
• W2121675132 hasConcept C126322002 @default.
• W2121675132 hasConcept C142724271 @default.
• W2121675132 hasConcept C143998085 @default.
• W2121675132 hasConcept C170493617 @default.
• W2121675132 hasConcept C188987157 @default.
• W2121675132 hasConcept C2777053506 @default.
• W2121675132 hasConcept C2777843972 @default.
• W2121675132 hasConcept C2779547902 @default.
• W2121675132 hasConcept C2779570518 @default.
• W2121675132 hasConcept C502942594 @default.
• W2121675132 hasConcept C71924100 @default.
• W2121675132 hasConcept C98274493 @default.
• W2121675132 hasConceptScore W2121675132C121608353 @default.
• W2121675132 hasConceptScore W2121675132C126322002 @default.
• W2121675132 hasConceptScore W2121675132C142724271 @default.
• W2121675132 hasConceptScore W2121675132C143998085 @default.
• W2121675132 hasConceptScore W2121675132C170493617 @default.
• W2121675132 hasConceptScore W2121675132C188987157 @default.
• W2121675132 hasConceptScore W2121675132C2777053506 @default.
• W2121675132 hasConceptScore W2121675132C2777843972 @default.
• W2121675132 hasConceptScore W2121675132C2779547902 @default.
• W2121675132 hasConceptScore W2121675132C2779570518 @default.
• W2121675132 hasConceptScore W2121675132C502942594 @default.
• W2121675132 hasConceptScore W2121675132C71924100 @default.
• W2121675132 hasConceptScore W2121675132C98274493 @default.
• W2121675132 hasLocation W21216751321 @default.
• W2121675132 hasOpenAccess W2121675132 @default.
• W2121675132 hasPrimaryLocation W21216751321 @default.
• W2121675132 hasRelatedWork W1511783960 @default.
• W2121675132 hasRelatedWork W1924499370 @default.
• W2121675132 hasRelatedWork W1977358854 @default.
• W2121675132 hasRelatedWork W1981015575 @default.
• W2121675132 hasRelatedWork W2022014232 @default.
• W2121675132 hasRelatedWork W2025075719 @default.
• W2121675132 hasRelatedWork W2025554600 @default.
• W2121675132 hasRelatedWork W2033965466 @default.
• W2121675132 hasRelatedWork W2056301346 @default.
• W2121675132 hasRelatedWork W2065576728 @default.
• W2121675132 hasRelatedWork W2070234213 @default.
• W2121675132 hasRelatedWork W2088302799 @default.
• W2121675132 hasRelatedWork W2101122879 @default.
• W2121675132 hasRelatedWork W2332078011 @default.
• W2121675132 hasRelatedWork W2557398941 @default.
• W2121675132 hasRelatedWork W2565337124 @default.
• W2121675132 hasRelatedWork W2591901249 @default.
• W2121675132 hasRelatedWork W2741843640 @default.
• W2121675132 hasRelatedWork W2808911266 @default.
• W2121675132 hasRelatedWork W3081713117 @default.
• W2121675132 isParatext "false" @default.
• W2121675132 isRetracted "false" @default.
• W2121675132 magId "2121675132" @default.
• W2121675132 workType "article" @default.